1 |
Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure |
|
|
| Daria A. Chestnykh,Davide Amato,Johannes Kornhuber,Christian P. Müller |
|
| Behavioural Brain Research. 2021; : 113144 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Haloperidol in palliative care: Indications and risks |
|
|
| Iwona Zaporowska-Stachowiak,Katarzyna Stachowiak-Szymczak,Mary-Tiffany Oduah,Maciej Sopata |
|
| Biomedicine & Pharmacotherapy. 2020; 132: 110772 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Differential benefits of olanzapine on executive function in schizophrenia patients: Preliminary findings |
|
|
| Neeti D. Mehta,Michelle J. Won,Shelly L. Babin,Saumil S. Patel,Adel A. Wassef,Alice Z. Chuang,Anne B. Sereno |
|
| Human Psychopharmacology: Clinical and Experimental. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia |
|
|
| Hannah E. Brown,Oliver Freudenreich,Xiaoduo Fan,Stephen O. Heard,Donald Goff,George Petrides,Amy L. Harrington,John M. Kane,Heidi Judge,Bettina Hoeppner,Maurizio Fava,Roy H. Perlis |
|
| JAMA Psychiatry. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
A case report of guardian-consent forced paliperidone palmitate for behavioral disturbance due to traumatic brain injury |
|
|
| Amber R. Douglass,Uyen Smyth |
|
| Mental Health Clinician. 2018; 8(3): 155 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Experiences of Family Carers for Persons Using Antipsychotic Medication |
|
|
| Paul Morrison,Norman Stomski |
|
| Australian and New Zealand Journal of Family Therapy. 2017; 38(3): 498 |
|
| [Pubmed] [Google Scholar] [DOI] |
|